Progress

Scientific American: Experimental Alzheimer’s Drug Significantly Slowed Patients’ Cognitive Decline - The surprising results have buoyed hopes for treatment By Damian Garde

After 18 months, patients who got the drug, called BAN2401, performed 30 percent better on a cognitive test than those getting placebo.